PURPOSE: Subfoveal choroidal neovascular membrane is an uncommon cause of visual impairment in children and that caused secondary to Best's disease is a well-known entity. However, limited experience exists in treatment of such lesions in the pediatric age group. This report describes the outcomes of treatment in three such eyes. METHODS: Three eyes of two children were treated with Verteporfin photodynamic therapy. One patient was observed up to 23 months and the other for up to 2 years. RESULTS: All three eyes were stabilized with a fair to good visual recovery. No ocular or systemic side effects were noted. CONCLUSION: Verteporfin photodynamic therapy may be a considered treatment option for childhood choroidal neovascular membranes secondary to Best's disease.
PURPOSE: Subfoveal choroidal neovascular membrane is an uncommon cause of visual impairment in children and that caused secondary to Best's disease is a well-known entity. However, limited experience exists in treatment of such lesions in the pediatric age group. This report describes the outcomes of treatment in three such eyes. METHODS: Three eyes of two children were treated with Verteporfin photodynamic therapy. One patient was observed up to 23 months and the other for up to 2 years. RESULTS: All three eyes were stabilized with a fair to good visual recovery. No ocular or systemic side effects were noted. CONCLUSION:Verteporfin photodynamic therapy may be a considered treatment option for childhood choroidal neovascular membranes secondary to Best's disease.